Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Characterizing the Radiochemical and Radiation Safety of RAD301 in Healthy Human Volunteers and Patients With Pancreatic Ductal Adenocarcinoma or Other Solid Tumors

NCT05799274 is registered in ClinicalTrials.gov with Radiopharm Theranostics, Ltd as lead sponsor.

NCT NCT05799274
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05799274 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Characterizing the Radiochemical and Radiation Safety of RAD301 in Healthy Human Volunteers and Patients With Pancreatic Ductal Adenocarcinoma or Other Solid Tumors
Lead sponsor
Radiopharm Theranostics, Ltd
Phase
Phase 1
Overall status
Active, not recruiting
Start date
November 9, 2023
Completion date
September 30, 2026
Enrollment
9 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

cervical cancer, endometrial cancer, esophageal squamous cell carcinoma, healthy volunteers, non-small cell lung cancer (nsclc), ovarian cancer, pancreatic ductal adenocarcinoma